BNR

Burning Rock Biotech (BNR)

About Burning Rock Biotech (BNR)

Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.

Details

Daily high
$18.87
Daily low
$16.20
Price at open
$16.20
52 Week High
$23.59
52 Week Low
$2.18
Market cap
169.3M
Dividend yield
0.00%
Volume
226,604
Avg. volume
74,385
P/E ratio
-11.66

Burning Rock Biotech News

Details

Daily high
$18.87
Daily low
$16.20
Price at open
$16.20
52 Week High
$23.59
52 Week Low
$2.18
Market cap
169.3M
Dividend yield
0.00%
Volume
226,604
Avg. volume
74,385
P/E ratio
-11.66